ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
Credit rating
Company information
About ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S
ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S (CVR number: 32323502) is a company from GENTOFTE. The company recorded a gross profit of -44610.5 kEUR in 2023. The operating profit was -44.6 mEUR, while net earnings were -44.5 mEUR. The profitability of the company measured by Return on Assets (ROA) was -199.6 %, which can be considered poor and Return on Equity (ROE) was -1321.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -100 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ASCENDIS PHARMA, OPHTHALMOLOGY DIVISION A/S's liquidity measured by quick ratio was 0.7 which is at a low level. Thus, the company may face difficulties in addressing its short-term obligations with its available liquid assets.
Financial information
See financialsGross profit (kEUR)
EBIT (kEUR)
Profitability
Solidity
Key figures (kEUR)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -1.85 | -30.40 | -6.05 | -8 328.99 | -44 610.52 |
EBIT | - 120.63 | - 125.71 | -94.08 | -8 418.53 | -44 619.27 |
Net earnings | 210.42 | 196.96 | 213.02 | -8 089.72 | -44 491.10 |
Shareholders equity total | 14 404.25 | 14 601.21 | 14 814.23 | 6 724.51 | -37 766.60 |
Balance sheet total (assets) | 14 411.94 | 14 611.69 | 14 821.58 | 6 733.38 | 7.64 |
Net debt | -5.62 | -21.65 | -17.06 | -11.63 | 37 756.18 |
Profitability | |||||
EBIT-% | |||||
ROA | 1.6 % | 1.6 % | 1.8 % | -75.1 % | -199.6 % |
ROE | 1.5 % | 1.4 % | 1.4 % | -75.1 % | -1321.8 % |
ROI | 1.6 % | 1.6 % | 1.8 % | -75.2 % | -199.7 % |
Economic value added (EVA) | - 811.60 | - 830.04 | - 806.61 | -9 153.34 | -44 488.44 |
Solvency | |||||
Equity ratio | 99.9 % | 99.9 % | 100.0 % | 99.9 % | -100.0 % |
Gearing | -100.0 % | ||||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1 872.2 | 1 394.1 | 2 015.2 | 758.7 | 0.7 |
Current ratio | 1 872.2 | 1 394.1 | 2 015.2 | 758.7 | 0.7 |
Cash and cash equivalents | 5.62 | 21.65 | 17.06 | 11.63 | 7.64 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | B | B | B | B | C |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.